This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 09:53, 18 April 2011 (Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 09:53, 18 April 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation ()(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Trimethoprim/polymyxin B" – news · newspapers · books · scholar · JSTOR (February 2011) (Learn how and when to remove this message) |
| Combination of | |
|---|---|
| Trimethoprim | Nucleic acid inhibitor antibiotic |
| Polymyxin | Cell envelope antibiotic |
| Clinical data | |
| Routes of administration | Eye drop |
| Identifiers | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| (verify) | |
The drug combination trimethoprim/polymyxin (INNs, trade name Polytrim) is an antimicrobial solution for topical ophthalmic use in the treatment of acute bacterial conjunctivitis and blepharoconjunctivitis.
Categories: